학술논문
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review
Document Type
Review Article
Author
Source
In Gynecologic Oncology August 2021 162(2):482-495
Subject
Language
ISSN
0090-8258